- Datum14.03.2025
- UhrzeitLäuft gerade
- Veranstalter
XTB
Jens Klatt
Moderator
GeoVax Labs Inc. Aktie
Verkaufen
Kaufen
GeoVax Labs Inc. Chart
GeoVax Labs Inc. Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| Nasdaq | VK | |||||
| Nasdaq Basic | VK | |||||
| Cboe BZX | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
3,25 %
Intraday
-7,02 %
1 Woche
-8,09 %
1 Monat
-35,63 %
Seit Jahresbeginn
-22,06 %
1 Jahr
-92,48 %
3 Jahre
-97,80 %
5 Jahre
Wikifolio
Passender Service zu GeoVax Labs Inc.
Webinar zu GeoVax Labs Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)1,090-11,180
- Jahrestief / Hoch ($)1,380-2,710
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von GeoVax Labs Inc.
Keine Dividenden verfügbar
Termine von GeoVax Labs Inc.
Keine aktuellen Termine
Beschreibung
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.
